Abstract
Ancillary and molecular testing of cytopathology specimens has emerged as a reliable and useful tool to provide diagnostic information and treatment-related biomarker status for the management of cancer patients. The cytology specimens obtained through minimally invasive means have proven suitable testing substrates for a variety of ancillary tests, including immunohistochemistry, fluorescence in situ hybridization, as well as polymerase chain reaction and next generation sequencing molecular techniques. By focusing specifically on the cytology specimen, this review provides an overview of basic testing considerations and assay selection in addition to updates on the ancillary testing of cytologic tumor specimens from the lung, salivary gland, and thyroid.
Original language | English (US) |
---|---|
Pages (from-to) | 403-414 |
Number of pages | 12 |
Journal | Journal of the American Society of Cytopathology |
Volume | 11 |
Issue number | 6 |
DOIs | |
State | Published - Nov 1 2022 |
Keywords
- Cytology
- FISH
- Lung
- Molecular testing
- Next generation sequencing
- Salivary gland
- Thyroid
ASJC Scopus subject areas
- Pathology and Forensic Medicine